Ignite Creation Date:
2025-12-24 @ 2:14 PM
Ignite Modification Date:
2025-12-29 @ 6:39 AM
Study NCT ID:
NCT00078195
Status:
COMPLETED
Last Update Posted:
2016-10-18
First Post:
2004-02-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-04
Start Date Type:
None
Primary Completion Date:
2005-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-05
Completion Date Type:
ACTUAL
First Submit Date:
2004-02-19
First Submit QC Date:
None
Study First Post Date:
2004-02-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-14
Last Update Post Date:
2016-10-18
Last Update Post Date Type:
ESTIMATED